St. Joseph's Health Care London
London, Ontario, N6C0A7, Canada
NCT Number: NCT06424483
Loneliness is a key predictor of mortality in older adults, and is a prominent risk factor for mental and physical illness in older adulthood. The goal of this study is to determine the feasibility and acceptability of a group loneliness intervention in geriatric psychiatry outpatients. This type of group loneliness intervention is based on functional analytic psychotherapy (FAP), called Awareness, Courage, and Love (ACL) Groups. The objective of this clinical trial is to adapt, implement, and evaluate the ACL group for outpatients.
This study is active but is not currently recruiting participants.
60 year and older
All sexes
Interventional
Not applicable
London, Ontario, N6C0A7, Canada
The objective of this clinical trial is to adapt, implement, and evaluate a type of loneliness group intervention called Awareness, Courage, and Love Groups for older adult outpatients diagnosed with a psychiatric disorder. The following research questions will be answered: (a) Are ACL groups with geriatric psychiatry outpatients feasible and acceptable? (b) Do such ACL groups demonstrate preliminary efficacy?
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Awareness, Courage, and Love (ACL) groups are an outgrowth of functional analytic psychotherapy, which is an empirically-based behavioural therapy that emphasizes the principle of positive reinforcement within relationships (Holman et al., 2017; Kanter et al., 2010; Kohlenberg & Tsai, 1991; Tsai et al., 2009a). Awareness involves the practice of mindfulness, and in particular, the noticing of emotions within oneself and in others (Tsai et al., 2009b). Courage refers to engaging in vulnerable self-disclosures and practicing boundaried support. Love encompasses healthy caring for oneself and others, and in particular, responding affirmingly to another person's self-disclosures.
Time frame: Up to 2 months
Brief measure of loneliness. The minimum value is 0, the maximum value is 11, and higher scores indicate a worse outcome.
Time frame: Up to 2 months
Measure of feasibility. Captured across 8 sessions, comparing pre to post.
Time frame: Up to 2 months
Brief measure of program satisfaction. The minimum value is 0, the maximum value is 16, and higher scores indicate a better outcome.
Time frame: Up to 2 months
Brief measure of loneliness. The minimum value is 6, the maximum value is 24, and higher scores indicate a worse outcome.
Time frame: Up to 2 months
1 item pictorial scale of subjective wellbeing from 0 (minimum) to 10 (maximum). A higher score indicates a better outcome.
Time frame: Up to 2 months
Brief single-item pictorial measure of social closeness. The minimum value is 1, the maximum value is 7, and higher scores indicate a better outcome.
Time frame: Up to 2 months
Brief measure of group relational health. The minimum value is 8, the maximum value is 40, and higher scores indicate a better outcome.
Time frame: Up to 2 months
Brief measure of perceived sacred qualities, adapted from Pargament et al. (2014). The minimum value is 11, the maximum value is 55, and higher scores indicate a better outcome.
Time frame: Up to 2 months
Brief open-ended questions about program satisfaction. Responses are qualitative.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Other
Awareness, Courage, and Love Group Psychotherapy for Geriatric Psychiatry Outpatients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07699588
Behavior, Loneliness
New York, United States
View Trial DetailsNCT07102017
Behavior, Behavioral Symptoms
Shanghai, China
View Trial DetailsNCT05522140
Behavior, Loneliness
Prague, Czechia
View Trial DetailsNCT05488496
Behavior, Loneliness
Barcelona, Spain
View Trial Details